Physician profile
Michael E Nelson
NPI 1821026295
$973.19
in general payments reported to CMS, 2019-2025
17 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $60.06 · 2021: $106 · 2022: $181 · 2023: $162 · 2024: $185 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $147.43 | 2019-2023 | |
| Lilly USA, LLC | $137.81 | 2023-2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $125.12 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $118.78 | 2023-2025 | Airsupra, Flumist Quadrivalent |
| Exact Sciences Corporation | $102.02 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sobi, INC | $74.97 | 2021-2023 | |
| Glaxosmithkline, LLC. | $61.69 | 2019-2025 | Shingrix |
| Sanofi Pasteur INC. | $51.70 | 2022-2025 | |
| Novo Nordisk INC | $29.83 | 2025 | Wegovy |
| Dynavax Technologies Corporation | $29.02 | 2025 | Heplisav-B |
| Genentech USA, INC. | $17.50 | 2022 | |
| Cranial Technologies, INC | $15.31 | 2020 | |
| Ironshore Pharmaceuticals INC. | $15.06 | 2019 | |
| Merck Sharp & Dohme LLC | $13.83 | 2022 | |
| Corium, LLC | $11.16 | 2023 | Azstarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $11.15 | 2021 | |
| Medtronic Vascular, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.